Abstract

IspH, a [4Fe-4S]-cluster-containing enzyme, catalyzes the reductive dehydroxylation of 4-hydroxy-3-methyl-butenyl diphosphate (HMBPP) to isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) in the methylerythritol phosphate pathway. Studies of IspH using fluoro-substituted substrate analogues to dissect the contributions of several factors to IspH catalysis, including the coordination of the HMBPP C4-OH group to the iron-sulfur cluster, the H-bonding network in the active site, and the electronic properties of the substrates are reported.
IspH is a [4Fe-4S]-cluster-containing enzyme found in the newly discovered isoprene biosynthetic pathway known as the methylerythritol phosphate (MEP) pathway.1 It catalyzes the last step of the MEP pathway by reductive dehydroxylation of the C4-OH group of 4-hydroxy-3-methyl-butenyl diphosphate (HMBPP, 1) to isopentenyl diphosphate (IPP, 2) and dimethylallyl diphosphate (DMAPP, 3, Figure 1), which are the two building blocks for all isoprenoids.2,3 While the MEP pathway is not present in humans, it is essential for many pathogenic microorganisms. Therefore, the enzymes involved in this pathway are attractive new targets for antimicrobial drugs.3,4 Early results showed that its labile [4Fe-4S] cluster contains a unique iron site,5,6,7,8,9,10 to which the C4-OH group of HMBPP binds (4 in Scheme 1).6,7,11 The bound HMBPP adopts a hairpin conformation in the active site with the carbon chain skeleton sandwiched between its pyrophosphate group and the [4Fe-4S] cluster (Figure 1).12 Due to the lack of a nearby proton source, protonation of the allylic anion intermediate (8, Scheme 1) during turnover has been proposed to be mediated by the terminal phosphate group of HMBPP.8,11,12
Figure 1.

Reaction catalyzed by IspH, and the IspH-HMBPP (1) complex in the active site. Due to the short distance (~ 2.9–3.0 Å) between the olefinic moiety (C2–C3) of 1 and the unique apical iron site, some interactions between the double bond of 1 and the iron-sulfur cluster may exist.
Scheme 1.
Proposed mechanisms for IspH-catalyzed reaction
Studies in recent years have led to three mechanistic models for IspH catalysis.5,8,11,13,14,15,16 Mechanism A proposed by Rohdich et al. (Scheme 1, route A) resembles a Birch reduction in which a one-electron transfer from the reduced iron-sulfur cluster to HMBPP (5 → 6) triggers the C4-deoxygenation from the nascent radical anion species (6) to form an allyl radical intermediate (7).11,14,15 Subsequent one-electron reduction (7 → 8) followed by protonation produces IPP (2) or DMAPP (3) depending on whether protonation occurs at C2 or C4 of 8. Mechanism B proposed by Wang et al. (Scheme 1, route B), is based mainly on the biophysical characterization of a paramagnetic species trapped in the IspH E126A mutant.17 In this organometallic model, formation of a substrate/metal π complex or an π2-alkenyl/metallacycle (9) followed by dehydration gives an π1-allyl intermediate (10). Upon the second one-electron transfer, 10 is reduced to an π3-allyl complex (11), which is then protonated to form IPP or DMAPP. Alternatively, in mechanism C (Scheme 1, route C) proposed by Altincicek et al.,13 the Lewis acidity of the metallo-center may facilitate the heterolytic cleavage of the C4-OH bond to form an allylic cation intermediate (12), which then undergoes two-electron reduction and protonation to yield the final products. Although coordination of the C4-OH group of HMBPP to the [4Fe-4S] cluster is important for all three proposed mechanisms, formation of metallocycle intermediates using the HMBPP olefinic moiety is specific for mechanism B, and the involvement of a cation intermediate is unique for mechanism C.
To learn more about the substrate specificity and to assess the energetic contributions of various interactions in the active site during IspH catalysis, a series of fluoro-substituted substrate analogues were synthesized and their competence as IspH substrates was examined (Scheme 2).18 The results and insights gained from these studies are reported herein.
Scheme 2.
Products produced from incubations of substrate analogues with IspH (please refer to Figure 1 for the distances between various atoms)
Previously, we reported that IspH can process the monofluoro analogue 13 to produce both IPP (2) and DMAPP (3) in a ratio of ~ 5:1.11 The kinetics of 13 as an IspH substrate was re-examined in this work by a more sensitive assay using methyl viologen, instead of flavodoxin-flavodoxin reductase, as the electron mediator.7 In the new assay, the IspH activity is nearly 100-fold higher than that of the NADPH-flavodoxin-flavodoxin reductase system.11 As listed in Table 1, the Km for 13 is 5.3-fold higher and kcat is 21.8-fold lower with a total of ~115-fold reduction of kcat/Km relative to that of HMBPP (1). Clearly, replacing the C4-OH group by a fluorine substituent affects overall catalysis. The reduction in catalysis may result from a combination of several factors. First, substitution of the C4-OH group by a fluorine atom will dramatically reduce the interaction between the substrate and the [4Fe-4S] cluster apical iron site because fluorine is a poor metal ligand. Second, the electronegativity difference between a fluoro and a hydroxyl group will change the electronic properties of the double bond, which in turn, may affect IspH activity. Third, the HMBPP C4 hydroxyl group is part of the H-bonding network shown in Figure 1. To dissect the relative contributions of the above factors to IspH catalysis, four additional substrate analogues, 14, 15, 17, and 18, were prepared and examined (Scheme 3 and Table 1).
Table 1.
Summary of activity using various mechanistic probes
| probes | kcat (min−1) | Km (μM | kcat/Kms (μM−1 · min−1) |
|---|---|---|---|
| 1 | 604 ± 17 | 19.7 ± 2.4 | 30.6 |
| 13 | 27.7 ± 2.2 | 104 ± 31 | 0.27 |
| 14 | 8.4 ± 1.9 | 489 ± 170 | 0.017 |
| 15 | 91.6 ± 2.2 | 447 ± 32 | 0.21 |
| 17 | No detectable activity | ||
| 18 | No detectable activity | ||
Scheme 3.
Mode of protonation of the allylic anion intermediate generated during turnover
The substrate analogue, 14, has the fluorine group at the C5 position instead of C4. Such a change should have little impact on the electronic properties of the olefin, but will affect the hydrogen-bond network with the active site residues T167 and E126. Thus, a comparison with analogue 13 may allow us to better assess the effect of the hydrogen-bonding network in IspH catalysis. As shown in Table 1, incubation of 14 with IspH showed that IspH can accept 14 as a substrate and produce IPP (2) as the sole product. In comparison with HMBPP (1), the Km for 14 is 25-fold higher, the kcat is 72-fold lower, and the kcat/Km is ~1783-fold reduced. The significant reduction in kcat/Km for 14 relative to 1 is not surprising and can be attributed to a combination of the lack of direct coordination of 14 to the apical iron site of the iron-sulfur cluster and the change in the electrophilic nature of the double bond. Notably, comparing 13 with 14, the Km for 14 is 4.7-fold higher, the kcat is 3.3-fold lower, and the kcat/Km is ~15.5-fold reduced. The observed activity differences between 13 and 14 suggest that the C4-fluoro group of 13 may still maintain partial hydrogen-bond interaction with the T167 and E126 side-chain rendering it a better substrate for IspH than 14.
To further probe the effects of the substrate electronic properties on IspH catalysis, (Z)-4,4,4-trifluoro-3-(hydroxymethyl)-but-2-en-1-yl diphosphate (15) was prepared. The strong electron withdrawing nature of the trifluoromethyl substituent will destablize the proposed allylic carbocation intermediate (12) which will in turn reduce the reaction rate to a great extent if mechanism C is operative. When 15 was incubated with IspH, 3-(trifluoromethyl)but-3-en-1-yl diphosphate (16) was produced as the only product (see Scheme 3).20 Clearly, IspH is capable of catalyzing the dehydroxylation of 15, but not the subsequent dehalogenation reaction. A similar outcome was also observed when (Z)-4,4,4-trifluoro-3-methyl-but-2-en-1-yl diphosphate (17) or (E)-4,4,4-trifluoro-3-methyl-but-2-en-1-yl diphosphate (18) was incubated with IspH and no product could be detected (Scheme 2). Although the kcat/Km value is reduced ~150-fold for 15 (compared to 1), the kcat is only 6.6-fold lower. This data suggests that route C is less likely as the mechanism for IspH. A similar conclusion was also reached in a recent report in which incubation of IspH with several proposed carbocationic intermediates caused little inhibition against IspH.19 The fact that the kcat for 15 is ~3.3-fold greater than that of the monofluoro analogue 13 and ~10.9-fold higher than that of the monofluoro analogue 14 again underscores the important role played by the C4 hydroxyl group in IspH catalysis.
The fact that only IPP (2) is produced in the reaction with 14 is intriguing since both IPP (2) and DMAPP (3) are formed when HMBPP (1) is used as the substrate. As shown in Scheme 3A, generation of 2 and 3 from 1 results from protonation of the proposed allylic anion intermediate 8 at C2 and C4, respectively. The proton donor is believed to be the terminal phosphate group of HMBPP, which is within ~3.4–3.5 Å of the C2 and C4 position of HMBPP (see Figure 1).12,20 In the case of 14, the negative charge of the proposed allylic anion intermediate (e.g., 19, Scheme 3B) is delocalized through C2, C3, and C5 instead of C2, C3, and C4 as shown in intermediate 8 (see Scheme 3A) The fact that protonation takes place only at C2, but not at C5 in 19, likely reflects the distance and unfavorable orientation of C5 of 19 relative to the phosphate group (e.g., OB) in the active site (e.g., ~4.6 Å between C5 and OB, Figure 1).
The conclusions reached based on the outcomes of these fluoro-analogues are also consistent with that derived from the incubation of IspH with a [13C]-labeled substrate analogue, 3-(hydroxymethyl)but-3-en-1-yl diphosphate ([5-13C]-20, Scheme 3C),21 which is expected to bind to [4Fe-4S]+ cluster in two different orientations depending on whether the reaction follows mechanism A or B. If the C4-OH of 20 is the anchor that positions the substrate in the active site (21 in Scheme 3D), protonation mediated by OB at C4 of the allylic anion intermediate (23, Scheme 3D, route a) would yield [13C]-IPP (2b) as the product (also see Figure 1). In contrast, if the reaction proceeds via an π2-alkenyl intermediate (22 in Scheme 3D), protonation of the allylic anion at the carbon closer to OB (now C5, Scheme 3D, route b) should afford [13C]-IPP (2c). The observation that 2b is the sole product after incubation strongly suggests that the C4-OH group, rather than the olefinic π-system, plays the dominant role in orienting the substrate in the active site, and thus favors the Birch reduction model. Together, these observations strongly indicate that protonation of the allylic anion intermediate (8, 19 or 23) occurs at C2 and/or C4, but not at C5.
In conclusion, the results obtained from these studies provide important insights into the mode of substrate binding and the mechanism of IspH. First, in view of the relatively minor influence of electron-withdrawing substituents on the reaction rate (e.g., 15), a mechanism involving a carbocationic intermediate/transition state is less likely. Second, coordination of the C4-OH group of HMBPP to the unique iron site of the [4Fe-4S] cluster and its involvement in the hydrogen-bond network (e.g., with T167 and E126) is crucial for efficient catalysis (13/14 versus 1, and 15 versus 17). The adverse effects (both steric and electronic) imposed by a trifluoromethyl substituent in 17 can be balanced by the introduction of a C4-OH group (15 versus 17). Third, protonation of the allylic anion intermediate is regiospecific and takes place only at C2 and/or C4 (see 8 → 2/3, 19 → 2, and 23 → 2b), but not at C5 (Scheme 3). These findings support the assigned role of the terminal phosphate group of HMBPP in mediating the final protonation step due to its close proximity to the C2 and C4 positions of the allylic anion intermediate (8, Schemes 1 and 3A). More experiments are in progress to further investigate this interesting example of an enzymatic reductive dehydroxylation reaction.
Supplementary Material
Acknowledgments
This work was supported in part by grants from the National Institutes of Health (GM040543 to H.-w.L. and GM093903 to P.L.) and the Welch Foundation (F-1511 to H.-w.L.) and NSF CAREER (CHE-0748504) to P.L.
Footnotes
Supporting Information Available: Details regarding experimental procedures, NMR characterization of the synthetic products as well as the incubation reactions. This material is available free of charge via the Internet at http://pubs.acs.org.
References
- 1.Rohmer M. Nat Prod Rep. 1999;16:565–574. doi: 10.1039/a709175c. [DOI] [PubMed] [Google Scholar]
- 2.Eisenreich W, Bacher A, Arigoni D, Rohdich F. Cell Mol Life Sci. 2004;61:1401–1426. doi: 10.1007/s00018-004-3381-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Thibodeaux CJ, Liu HW. Chimia. 2009;63:334–339. [Google Scholar]
- 4.Oldfield E. Acc Chem Res. 2010;43:1216–1226. doi: 10.1021/ar100026v. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Wolff M, Seemann M, Tse Sum Bui B, Frapart Y, Tritsch D, Garcia Estrabot A, Rodríguez-Concepción M, Boronat A, Marquet A, Rohmer M. FEBS Lett. 2003;541:115–120. doi: 10.1016/s0014-5793(03)00317-x. [DOI] [PubMed] [Google Scholar]
- 6.Seemann M, Janthawornpong K, Schweizer J, Bottger LH, Janoschka A, Ahrens-Botzong A, Tambou MN, Rotthaus O, Trautwein AX, Rohmer M, Schunemann V. J Am Chem Soc. 2009;131:13184–13185. doi: 10.1021/ja9012408. [DOI] [PubMed] [Google Scholar]
- 7.Xiao Y, Chu L, Sanakis Y, Liu P. J Am Chem Soc. 2009;131:9931–9933. doi: 10.1021/ja903778d. [DOI] [PubMed] [Google Scholar]
- 8.Gräwert T, Rohdich F, Span I, Bacher A, Eisenreich W, Eppinger J, Groll M. Angew Chem Int Ed Engl. 2009;48:5756–5759. doi: 10.1002/anie.200900548. [DOI] [PubMed] [Google Scholar]
- 9.Rekittke I, Wiesner J, Rohrich R, Demmer U, Warkentin E, Xu WY, Troschke K, Hintz M, No JH, Duin EC, Oldfield E, Jomaa H, Ermler U. J Am Chem Soc. 2008;130:17206–17207. doi: 10.1021/ja806668q. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Gräwert T, Kaiser J, Zepeck F, Laupitz R, Hecht S, Amslinger S, Schramek N, Schleicher E, Weber S, Haslbeck M, Buchner J, Rieder C, Arigoni D, Bacher A, Eisenreich W, Rohdich F. J Am Chem Soc. 2004;126:12847–12855. doi: 10.1021/ja0471727. [DOI] [PubMed] [Google Scholar]
- 11.Xiao Y, Zhao ZK, Liu P. J Am Chem Soc. 2008;130:2164–2165. doi: 10.1021/ja710245d. [DOI] [PubMed] [Google Scholar]
- 12.Gräwert T, Span I, Eisenreich W, Rohdich F, Eppinger J, Bacher A, Groll M. Proc Natl Acad Sci USA. 2010;107:1077–1081. doi: 10.1073/pnas.0913045107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Altincicek B, Duin EC, Reichenberg A, Hedderich R, Kollas AK, Hintz M, Wagner S, Wiesner J, Beck E, Jomaa H. FEBS Lett. 2002;532:437–440. doi: 10.1016/s0014-5793(02)03726-2. [DOI] [PubMed] [Google Scholar]
- 14.Rohdich F, Zepeck F, Adam P, Hecht S, Kaiser J, Laupitz R, Gräwert T, Amslinger S, Eisenreich W, Bacher A, Arigoni D. Proc Natl Acad Sci USA. 2003;100:1586–1591. doi: 10.1073/pnas.0337742100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Xiao Y, Liu P. Angew Chem Int Ed Engl. 2008;47:9722–9725. doi: 10.1002/anie.200803452. [DOI] [PubMed] [Google Scholar]
- 16.Wang W, Wang K, Liu YL, No JH, Li J, Nilges MJ, Oldfield E. Proc Natl Acad Sci USA. 2010;107:4522–4527. doi: 10.1073/pnas.0911087107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Wang W, Li J, Wang K, Huang C, Zhang Y, Oldfield E. Proc Natl Acad Sci USA. 2010;107:11189–11193. doi: 10.1073/pnas.1000264107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Syntheses of all of the substrate analogues listed in Scheme 2 are included in the Supporting Information. These compounds were evaluated as IspH substrates by a recently developed assay.7 After incubation of substrate analogues with IspH, the reaction mixture was purified by HPLC, and the turnover products were isolated and characterized by 1H-NMR and high-resolution mass spectrometry. The identities of these products were further confirmed by comparison with synthetic standards (see supporting information).
- 19.Wang K, Wang W, No JH, Zhang Y, Zhang Y, Oldfield E. J Am Chem Soc. 2010;132:6719–6727. doi: 10.1021/ja909664j. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Gräwert T, Span I, Bacher A, Groll M. Angew Chem Int Ed Engl. 2010;49:8802–8809. doi: 10.1002/anie.201000833. [DOI] [PubMed] [Google Scholar]
- 21.Chang W-c, Xiao Y, Liu H-w, Liu P. Angew Chem Int Ed Engl. 2011 in press. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.



